Clinical trials
Phase 3 Fatty Liver trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 3 |
| 2008 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 5 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 89bio, Inc. | 2 |
| GlaxoSmithKline | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| Sanofi | 2 |
| Eli Lilly and Company | 1 |
| US Department of Veterans Affairs | 1 |
| University of Colorado, Denver | 1 |
| Virginia Commonwealth University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fatty Liver | 12 |
| Non-alcoholic Fatty Liver Disease | 10 |
| Fibrosis | 5 |
| Liver Diseases | 3 |
| Digestive System Diseases | 2 |
| Metabolic Diseases | 2 |
| Hepatitis | 1 |
| Obesity | 1 |
| Pediatric Obesity | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.